← Back to Search

Patient Communication Platform

Text-Messaging Platform for Musculoskeletal Disorders

N/A
Recruiting
Led By Paul Tornetta III, MD
Research Sponsored by Boston Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Speak either English or English as a primary language:
Ankle Fracture
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights

Study Summary

This trial is testing whether a text-messaging platform can be used to effectively collect patient-reported outcome measures in order to right-size clinic visits.

Who is the study for?
This trial is for orthopedic patients with specific conditions like lumbar fusion, ACL reconstruction, or rotator cuff repair. Participants must have a personal cell phone with internet and speak English primarily. It's not for incarcerated individuals, those who can't read well, or without a cell phone.Check my eligibility
What is being tested?
The study tests the use of Memora Health's text-messaging platform to collect patient-reported outcomes via PROMIS CAT surveys and then tailor clinic visits accordingly. The goal is to improve communication and care efficiency in two phases.See study design
What are the potential side effects?
Since this trial involves using a text-messaging platform rather than medication or invasive procedures, traditional side effects are not applicable. However, participants may experience issues related to privacy concerns or data usage.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I speak English or English is my primary language.
Select...
I have a broken ankle.
Select...
I have been diagnosed with lumbar stenosis.
Select...
I have had surgery to repair my rotator cuff.
Select...
I have had surgery to remove a disc from my neck and fuse the bones.
Select...
I had surgery to fix a broken bone in my knee using screws or plates.
Select...
I am scheduled for or have had spine surgery.
Select...
I have had surgery to relieve pressure on my spinal nerves.
Select...
I have had ACL reconstruction surgery.
Select...
I have had surgery to remove part of a bone in my neck.
Select...
I have a broken wrist.
Select...
I have had a lumbar fusion surgery.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Patient-based recovery curves for specific orthopedic conditions
Right-size clinic visits for specific orthopedic conditions
Secondary outcome measures
Average number of PROMs collected during clinic visits
Average number of PROMs collected through SMS and weblink

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Phase 2Experimental Treatment1 Intervention
Participants in Phase 2 will have their clinic visits potentially revised based on the phase 1 recovery curves which may increase or decrease the number of clinic visits they receive based on the PROMs reported.
Group II: Phase 1Active Control1 Intervention
Participants in phase 1 will be observed and data about their recovery time will be collected from which recovery curves will be calculated for Phase 2

Find a Location

Who is running the clinical trial?

Boston Medical CenterLead Sponsor
383 Previous Clinical Trials
868,150 Total Patients Enrolled
Paul Tornetta III, MDPrincipal InvestigatorBoston Medical Center

Media Library

Right-Size Clinic Visits (Patient Communication Platform) Clinical Trial Eligibility Overview. Trial Name: NCT04441567 — N/A
Orthopedic Disorders Research Study Groups: Phase 1, Phase 2
Orthopedic Disorders Clinical Trial 2023: Right-Size Clinic Visits Highlights & Side Effects. Trial Name: NCT04441567 — N/A
Right-Size Clinic Visits (Patient Communication Platform) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04441567 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any remaining openings for participants in this clinical trial?

"Yes, the information on clinicaltrials.gov confirms that this trial is actively recruiting participants. This investigation was posted on May 10th 2021 and has been updated most recently on May 10th 2022. The research requires 3000 patients to be recruited from a single medical centre."

Answered by AI

How many individuals are signing up for this experiment?

"Affirmative. Evidenced on clinicaltrials.gov, this study is actively enrolling patients; the trial was first made publically available on May 10th 2021 and was last revised on May 10th 2022. The research team needs to recruit 3000 participants from at least 1 medical site."

Answered by AI
~812 spots leftby Jun 2025